Core Scientific Inctx
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
6 — Balance Sheet Components
- BALANCE SHEET COMPONENTS
Accrued expenses and other current liabilities as of December 31, 2024 and 2023, consist of the following (in thousands):
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Accrued compensation | $34,184 | $593 |
| Accrued liabilities | 249 | 38,288 |
| Accrued capital expenditures | 12,106 | 416 |
| Accrued interest | 5,101 | 94,311 |
| Other current liabilities | 17,590 | 46,028 |
| Total accrued expenses and other current liabilities | $69,230 | $179,636 |
1 Certain prior year amounts have been reclassified for consistency with the current year presentation.
Accrued liabilities includes expenses related audit fees and security services. In 2023, accrued liabilities also included expenses related to settlements. Other current liabilities represents purchases of miners, taxes payable, energy costs, and other operating costs.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.